logo

For the Inventor, By the Inventor

Briarcliff Manor, NY, United States of America

Ameen F Ghannam

This inventor holds 9 USPTO granted patents. Top assignees: Schering Aktiengesellschaft, Abbott Laboratories Corporation. Active years: 2001-2007.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Ameen F Ghannam. Retrieved from https://idiyas.com/inventor/ameen-f-ghannam

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 9

% Patents Active = 66.7

Average Co-Inventor Count = 12.7

ph-index = 4

Forward Citations = 66(Granted Patents)


Location History:

  • Oakland, CA (US) (2001)
  • Briarcliff Manor, NY (US) (2003 - 2007)

Company Filing History:

goldMedal8 out of 1,409 
 
Schering Aktiengesellschaft
 patents
silverMedal1 out of 4,190 
 
Abbott Laboratories Corporation
 patents

Years Active: 2001-2007

Loading Chart...
9 patents (USPTO):Explore Patents
1. 7268140 - Piperazine derivatives and their use as anti-inflammatory agents (2007-09-11),
2. 6977258 - Piperazine derivatives and their use as anti-inflammatory agents (2005-12-20),
3. 6972290 - Piperazine derivatives and their use as anti-inflammatory agents (2005-12-06),
4. 6573266 - Piperazine derivatives and their use as anti-inflammatory agents (2003-06-03),
5. 6555537 - Piperazine derivatives and their use as anti-inflammatory agents (2003-04-29),
6. 6541476 - Piperazine derivatives and their use as anti-inflammatory agents (2003-04-01),
7. 6534509 - Piperazine derivatives and their use as anti-inflammatory agents (2003-03-18),
8. 6207665 - Piperazine derivatives and their use as anti-inflammatory agents (2001-03-27),
9. 6191285 - Process for the preparation of ketorolac tromethamine (2001-02-20),

Title: Ameen F Ghannam: Innovator in Anti-Inflammatory Agents

Introduction

Ameen F Ghannam is a notable inventor based in Briarcliff Manor, NY (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of anti-inflammatory agents. With a total of 9 patents to his name, Ghannam's work has the potential to impact the treatment of various inflammatory disorders.

Latest Patents

One of Ghannam's latest patents focuses on piperazine derivatives and their use as anti-inflammatory agents. This invention is directed to acyl piperazine derivatives that are useful in treating inflammatory disorders in humans. The patent also includes pharmaceutical compositions containing these compounds and methods for their application. Another related patent elaborates on acyl piperazine derivatives of a specific formula, which are similarly aimed at addressing inflammatory conditions.

Career Highlights

Throughout his career, Ameen F Ghannam has worked with prominent companies in the pharmaceutical industry, including Schering Aktiengesellschaft and Abbott Laboratories Corporation. His experience in these organizations has contributed to his expertise in drug development and innovation.

Collaborations

Ghannam has collaborated with notable professionals in his field, including John G Bauman and Brad Owen Buckman. These partnerships have likely enhanced his research and development efforts, leading to successful patent applications.

Conclusion

Ameen F Ghannam's contributions to the field of anti-inflammatory agents through his innovative patents demonstrate his commitment to advancing medical science. His work continues to pave the way for new treatments that can improve the quality of life for individuals suffering from inflammatory disorders.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…